UK markets open in 3 hours 32 minutes

Inari Medical, Inc. (NARI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
60.05+1.79 (+3.07%)
At close: 04:00PM EST
60.05 0.00 (0.00%)
After hours: 04:02PM EST

Inari Medical, Inc.

6001 Oak Canyon
Suite 100
Irvine, CA 92618
United States
877 923 4747
https://www.inarimedical.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees1,100

Key executives

NameTitlePayExercisedYear born
Mr. Andrew J. HykesCEO, President & Director863.78k800.42k1974
Mr. Mitchell C. HillChief Financial Officer811.08k5.86M1959
Dr. Thomas M. Tu M.D.Chief Medical Officer812.94k2.85M1973
Mr. Paul A. KoehnSenior Vice President of OperationsN/AN/A1963
Mr. Kevin StrangeSenior Vice President of Finance, Accounting, Strategy & Business DevelopmentN/AN/AN/A
Mr. John Hsu C.F.A.Vice President of Investor RelationsN/AN/AN/A
Ms. Angela AhmadGeneral Counsel & SecretaryN/AN/AN/A
Mr. Eric KhairySenior Vice President of MarketingN/AN/AN/A
Mr. John R. BorrellSenior Vice President of SalesN/AN/A1967
Ms. Tara DunnSenior Vice President of Clinical Affairs & Market DevelopmentN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Corporate governance

Inari Medical, Inc.’s ISS governance QualityScore as of 28 November 2023 is 6. The pillar scores are Audit: 2; Board: 6; Shareholder rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.